11月1日，近日，在上海静安区"美创静界"美妆健康创新生态社区，逸仙集团正式发布《逸仙集团美妆 创新白皮书》，这也是"中国首份美妆创新白皮书"。 逸仙集团创始人、董事长兼CEO黄锦峰在发布会致辞中指出，这份《美妆创新白皮书》是集团过去几年 研发积累的阶段性成果总结，也是向行业、向社会公开展示研发战略、技术成果与未来方向的重要窗 口。"我们相信，世界级的美妆创新，可以诞生在中国；世界级的科研实力，可以点亮中国品牌的未 来。"他表示。 发布会上，集团重点揭晓了DR.WU达尔肤PDRN水光精华核心技术成果。据悉，该产品是逸仙集团全链 路协同创新的成果。集团携手华中科技大学国家纳米药物工程技术研究中心，共同开发出诺奖应用同 源、基于医药领域RNA疫苗纳米脂质粒包裹递送技术的'Nanoxinfuse™'包裹促渗技术，以独家专利打造 核心成分'超渗PDRN Pro'有效提升活性成分的渗透力与稳定性；同时，团队引入AI分子对接技术，通 过SuperPred预测靶蛋白、AlphaFold3解析三维结构，计算分子亲和力，精准筛选出三大PDRN功效放大 器，实现了成分的智能协同与功效增强。该产品可有效修护焕活胶原母细胞，4h直达 ...

Core Insights - The launch of the "Yatsen Group Beauty Innovation White Paper" marks a significant milestone for China's beauty technology, positioning it among the global leaders in research and development [1][3][5] Group 1: White Paper Overview - The white paper is the first of its kind in China, systematically outlining Yatsen Group's achievements in global research layout, technological innovation, efficacy verification, and sustainable development [3][5] - It serves as a window to showcase the company's R&D strategy, technological achievements, and future directions, reflecting the potential for world-class beauty innovation to emerge from China [5][12] Group 2: Industry Context - The Chinese cosmetics industry is currently in a critical phase of innovation-driven development, with the white paper providing valuable insights and foresight into future trends [7][9] - The release of the white paper is seen as a vital contribution to the ongoing transformation of the Chinese cosmetics industry, injecting new wisdom and vitality [7][9] Group 3: Research and Development Achievements - Yatsen Group has established a comprehensive "end-to-end" innovation system, integrating research, formulation development, efficacy validation, and manufacturing [18][20] - The company has invested over 600 million yuan in R&D since its NYSE listing in 2020, maintaining a R&D expense ratio exceeding 3% for three consecutive years, placing it among the top tier in the global beauty industry [17][20] Group 4: Product Innovations - The launch of the DR.WU PDRN Water Light Essence showcases the application of advanced technologies, including AI molecular docking and a patented delivery system, enhancing the efficacy of active ingredients [14][16] - The white paper highlights multiple innovative achievements, including the introduction of the Biotec™ technology, which integrates Nobel Prize-winning science into beauty products [16][18] Group 5: Financial Performance - Yatsen Group reported a revenue of 1.09 billion yuan for Q2 2025, a year-on-year increase of 36.8%, with a gross profit margin of 78.3% [21] - The skincare segment has shown remarkable growth, contributing 53.5% to total revenue, indicating the effectiveness of the company's R&D-driven growth strategy [21]

Core Viewpoint - Yatsen Group has officially launched the "Yatsen Group Beauty Innovation White Paper," marking a significant milestone in China's beauty technology innovation and positioning it among the global R&D leaders [2][4][5]. Group 1: White Paper Overview - The white paper is structured around "innovation" and consists of six major sections, detailing the group's global research layout, technological innovations, efficacy verification, and sustainable development [5]. - It serves as a summary of Yatsen Group's R&D achievements over the past few years and aims to showcase its research strategy, technological outcomes, and future directions to the industry and society [7][13]. Group 2: Industry Insights - The white paper reflects the current critical phase of innovation-driven development in China's cosmetics industry, providing insights into cutting-edge beauty technology and future trends [9]. - It is seen as a vital resource for fostering collaboration and innovation within the industry, especially during a period of transformation and upgrading [9]. Group 3: R&D Achievements - Yatsen Group's R&D investments and system construction have reached international standards, with a focus on translating research into consumer products, particularly in the field of acne treatment [11]. - The launch of the DR.WU PDRN Water Light Essence, which utilizes advanced technology to deliver medical-grade effects at home, exemplifies the company's commitment to innovation [15]. Group 4: Innovation Ecosystem - The company has established an efficient innovation ecosystem by integrating industry, academia, medicine, and basic research, supported by AI technology [17]. - Yatsen Group's open lab model promotes rapid translation of research outcomes into market-ready products, collaborating with various prestigious institutions [17][18]. Group 5: Financial Performance - Since its listing on the NYSE in 2020, Yatsen Group has consistently prioritized R&D, with cumulative R&D expenses exceeding 600 million yuan, maintaining a R&D expense ratio above 3% for three consecutive years [19][22]. - The company reported a revenue of 1.09 billion yuan for Q2 2025, a year-on-year increase of 36.8%, with a gross profit margin of 78.3% and skincare business revenue growth of 78.7% [22][23].

Core Insights - Yatsen Group has officially released the "Yatsen Group Beauty Innovation White Paper," emphasizing "innovation" as the main theme [1] Group 1: Research and Development - The white paper is divided into six major sections, systematically outlining the group's global research and development layout [1] - It presents a comprehensive view of Yatsen Group's strategic depth in Chinese beauty research and its international breadth [1] Group 2: Technological Innovation - The report details the company's achievements in technological innovation, efficacy verification, and sustainable development [1] - It highlights the systematic results of the group's efforts in these areas [1]